Acro Biomedical (ACBM) Invested Capital (2016 - 2022)

Acro Biomedical has reported Invested Capital for 7 years, with the latest figure at $565196.0 in Q4 2022.

• On a quarterly basis, Invested Capital fell 14.94% year-over-year to $565196.0 in Q4 2022; TTM through Dec 2022 was $565196.0, a 14.94% decrease from a year earlier, with the FY2022 full-year figure at $565196.0, down 14.94% from the prior year.
• Invested Capital was $565196.0 for Q4 2022 at Acro Biomedical, down from $570758.0 in the prior quarter.
• The five-year high for Invested Capital was $1.4 million in Q3 2018, with the low at $565196.0 in Q4 2022.
• Average Invested Capital over 5 years is $849620.0, with a median of $902099.5 recorded in 2018.
• The sharpest annual moves came in 2018 and 2021: Invested Capital soared 48402.89% in 2018, then slumped 37.02% in 2021.
• Over 5 years, Invested Capital stood at $1.2 million in 2018, then decreased by 29.6% to $824518.0 in 2019, then rose by 12.65% to $928819.0 in 2020, then slipped by 28.46% to $664448.0 in 2021, then slipped by 14.94% to $565196.0 in 2022.
• The last three Invested Capital figures came in at $565196.0 (Q4 2022), $570758.0 (Q3 2022), and $596132.0 (Q2 2022), per Business Quant data.